在中风患者中预后的预测因素,其中包括患有合病变的患者,这些患者接受了新兴支架
Leyla Ramazanoglu1, Isil Kalyoncu Aslan1, Yilmaz Onal2
1Department of Neurology, University of Health Sciences Fatih Sultan Mehmet Training and Research Hospital, Turkey.
The neuroradiology journal
|February 5, 2025
概括
脑卒中患者有双重病变,正在接受新兴支架,从24小时的NIHSS得分和年龄的监测中受益. 这些因素预测内血管血栓切除术后的预后不佳和死亡率.
科学领域:
- 神经学 神经学
- 干预心脏病学 干预心脏病学
- 血管外科 血管外科
背景情况:
- 双重病变 (头骨外动脉和头骨内大血管封闭) 的最佳内血管治疗仍然不清楚.
- 这项研究评估了新出现的额外支架结合内机械血栓切除术 (MT) 对中风患者的结果.
研究的目的:
- 评估随访结果,并确定在接受内血管治疗的双重病变中风患者中预后不良和死亡率的预测因素.
- 为了确定预测死亡率的最佳年龄截止值.
主要方法:
- 追溯分析71名中风患者的双重病变治疗新兴的额外头骨支架和MT.
- 评估已修改的兰金尺度 (mRS) 评分,症状性内出血 (sICH),美国国立卫生研究院中风尺度 (NIHSS) 评分,再通道化和各种时间点 (90天,1年,2年) 的并发症.
主要成果:
- 高24小时NIHSS得分和脑外并发症独立预测了所有随访点的不良预后.
- 67岁的年龄截止值是预测1年死亡率的最佳值 (AUC = 0.802).
- 在sICH和预后之间没有发现任何显著的关联.
结论:
- 再输血后的24小时NIHSS得分和患者年龄是中风患者中预后不良和死亡率的重要预测因素,中风患者有双重病变,在血栓切除术期间接受新兴支架治疗.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.


